Guo H - Search Results

1

Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD-L1.

Ding L, Guo H, Zhang J, Zheng M, Zhang W, Wang L, Du Q, Zhou C, Xu Y, Wu H, He Q, Yang B. Ding L, et al. Among authors: guo h. Adv Sci (Weinh). 2024 Nov;11(41):e2400340. doi: 10.1002/advs.202400340. Epub 2024 Sep 4. Adv Sci (Weinh). 2024. PMID: 39229920 Free PMC article.

2

Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses.

Chen X, Pan X, Zhang W, Guo H, Cheng S, He Q, Yang B, Ding L. Chen X, et al. Among authors: guo h. Acta Pharm Sin B. 2020 May;10(5):723-733. doi: 10.1016/j.apsb.2019.09.006. Epub 2019 Sep 25. Acta Pharm Sin B. 2020. PMID: 32528824 Free PMC article. Review.

3

Ceritinib increases sensitivity of AKT inhibitors to gastric cancer.

Wang J, Xu X, Wang T, Guo Q, Dai X, Guo H, Zhang W, Cheng S, Chen X, Ding L. Wang J, et al. Among authors: guo q, guo h. Eur J Pharmacol. 2021 Apr 5;896:173879. doi: 10.1016/j.ejphar.2021.173879. Epub 2021 Jan 28. Eur J Pharmacol. 2021. PMID: 33515539 Free article.

4

Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1.

Pan X, Li R, Guo H, Zhang W, Xu X, Chen X, Ding L. Pan X, et al. Among authors: guo h. Front Pharmacol. 2021 Jan 13;11:539261. doi: 10.3389/fphar.2020.539261. eCollection 2020. Front Pharmacol. 2021. PMID: 33519429 Free PMC article.

5

Tackling drug resistance in ovarian cancer with epigenetic targeted drugs.

Zhao L, Guo H, Chen X, Zhang W, He Q, Ding L, Yang B. Zhao L, et al. Among authors: guo h. Eur J Pharmacol. 2022 Jul 15;927:175071. doi: 10.1016/j.ejphar.2022.175071. Epub 2022 May 27. Eur J Pharmacol. 2022. PMID: 35636522 Review.

6

Bafetinib Suppresses the Transcription of PD-L1 Through c-Myc in Lung Cancer.

Chen X, Du Q, Guo H, He Q, Yang B, Ding L. Chen X, et al. Among authors: guo h. Front Pharmacol. 2022 Jun 2;13:897747. doi: 10.3389/fphar.2022.897747. eCollection 2022. Front Pharmacol. 2022. PMID: 35721177 Free PMC article.

7

The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies.

Zhong T, Zhang W, Guo H, Pan X, Chen X, He Q, Yang B, Ding L. Zhong T, et al. Among authors: guo h. Acta Pharm Sin B. 2022 Apr;12(4):1761-1780. doi: 10.1016/j.apsb.2021.11.001. Epub 2021 Nov 5. Acta Pharm Sin B. 2022. PMID: 35847486 Free PMC article. Review.

8

Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.

Ding L, Chen X, Zhang W, Dai X, Guo H, Pan X, Xu Y, Feng J, Yuan M, Gao X, Wang J, Xu X, Li S, Wu H, Cao J, He Q, Yang B. Ding L, et al. Among authors: guo h. J Clin Invest. 2023 Jan 3;133(1):e154754. doi: 10.1172/JCI154754. J Clin Invest. 2023. PMID: 36594471 Free PMC article.

9

The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy.

Zheng M, Zhang W, Chen X, Guo H, Wu H, Xu Y, He Q, Ding L, Yang B. Zheng M, et al. Among authors: guo h. Acta Pharm Sin B. 2023 Apr;13(4):1488-1497. doi: 10.1016/j.apsb.2022.10.027. Epub 2022 Nov 2. Acta Pharm Sin B. 2023. PMID: 37139414 Free PMC article. Review.

10

Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.

Pan X, Zhang W, Guo H, Wang L, Wu H, Ding L, Yang B. Pan X, et al. Among authors: guo h. Biochem Pharmacol. 2023 Jul;213:115596. doi: 10.1016/j.bcp.2023.115596. Epub 2023 May 16. Biochem Pharmacol. 2023. PMID: 37201875 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,036 results

Search Page

Filters